Insights
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
11 June 2025
As healthcare systems strive to allocate resources efficiently, the use of economic evaluation metrics like Quality-Adjusted Life Years (QALYs) has become increasingly important.
Around the world in HTAs: Argentina – Long Road to Institutionalizing HTA
9 June 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés Pichon-Riviere, Federico Augustovski, and Martina Garau take us to Argentina.
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS England, NICE, the University of Manchester, and Bangor University.
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
We know that immunisation pays off: the wider societal benefits of childhood immunisation programmes in low and middle income countries outweigh their costs up to 51 times while…
Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order
2 June 2025
This is the first in a series of OHE Insights on the history, implications and possible impact of President Trump’s Executive Order on a “Most Favoured Nation” (MFN) pricing model for pharmaceuticals.
OHE submission to the UK Parliamentary Inquiry on an Ageing Society
20 May 2025
OHE’s written submission to parliament focused on raising population health in older age and increasing access to fertility treatments as two possible avenues to address the challenges of demographic change.
Around the World in HTAs: Kenya – Riding the Waves of Change
19 May 2025
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Angela Kairu and Edwine Barasa of the KEMRI Wellcome Trust Research Programme, and Paul Oyalo of OHE, take us to Kenya.
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
The glucagon-like peptide-1 (GLP-1) receptor agonist market is experiencing rapid growth, with more than 150 drug candidates currently in development as reported by Research & Markets,…
Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next
10 April 2025
As part of EuroQol’s current priority-setting work, the development of bolt-ons for the EQ-5D-5L instrument has taken centre stage. A “bolt-on toolbox” is being developed to…